Morepen Laboratories balance sheet

As of Sep 2026

Total assets: ₹2,306cr+32.8% on Sep 2025
Shareholders' equity: ₹1,382cr+15.5% on Sep 2025
Total debt: ₹305cr+110.0% on Sep 2025
Cash and investments: ₹171cr+132.1% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	421	381	317	213	167
	22.8	21.6	28.3	24.5	17.0
	0.0	0.0	74.5	74.5	74.5
	162	132	97.5	19.7	25.5
	102	101	7.2	1.3	0.0
	0.1	0.1	0.1	0.0	0.0
	7.6	7.6	7.8	7.1	6.4
	109	109	15.1	8.5	6.4
	151	129	86.8	63.9	63.9
	866	773	619	404	354
	324	272	300	249	229
	16.3	22.9	77.8	0.0	0.0
	345	333	325	325	263
	155	31.2	27.4	16.9	21.7
	99.7	37.6	22.0	35.2	34.6
	0.5	0.5	0.5	0.2	0.3
	13.4	16.0	11.3	14.4	5.5
	629	441	464	392	325
	487	451	396	249	202
	1,440	1,164	1,159	889	756
	2,306	1,936	1,778	1,293	1,110
Equity
	110	110	110	102	102
	1,272	1,137	1,047	745	651
	1,381	1,246	1,156	847	753
	0.8	0.7	30.7	0.0	−0.5
	1,382	1,247	1,187	847	752
Liabilities
	121	134	25.8	3.4	0.9
	12.0	7.4	17.9	4.5	3.5
	133	141	43.7	7.9	4.5
	41.5	41.2	39.8	33.8	29.7
	23.4	16.5	7.0	2.2	2.7
	198	199	90.5	43.9	36.9
	184	61.1	53.6	25.6	24.2
	408	317	363	295	227
	73.9	44.2	42.5	50.5	50.1
	666	423	459	371	301
	42.4	29.6	19.6	25.0	16.2
	17.8	38.1	21.6	5.9	3.7
	726	490	501	402	321
	924	689	591	446	358
	2,306	1,936	1,778	1,293	1,110
Trade payables — MSME split
	2.1	2.9	0.7	—	—
	406	314	363	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MOREPENLAB₹125.58

Morepen Laboratories Limited

· Pharma & Health

₹ CrorePeersIOLCP INNOVACAP FDC ORCHPHARMA SENORES SANOFI GUJTHEM RPGLIFEMcap ₹6,881 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	167.0	213.2	316.5	381.2	421.4
+ Capital Work-in-Progress	17.0	24.5	28.3	21.6	22.8
+ Goodwill	74.5	74.5	74.5	0.0	0.0
+ Other Intangibles	25.5	19.7	97.5	131.8	161.6
+ Non-current Investments	0.0	1.3	7.2	101.3	101.8
+ Long-term Loans	0.0	0.0	0.1	0.1	0.1
+ Other Non-current Financial Assets	6.4	7.1	7.8	7.6	7.6
Non-current Financial Assets	6.4	8.5	15.1	108.9	109.5
+ Other Non-current Assets	63.9	63.9	86.8	129.0	150.8
Total Non-current Assets	354.3	404.2	618.7	772.5	866.0
Current Assets
+ Inventories	228.9	248.6	300.0	271.8	323.6
+ Current Investments	0.0	0.0	77.8	22.9	16.3
+ Trade Receivables	263.2	324.9	324.8	333.1	344.5
+ Cash & Cash Equivalents	21.7	16.9	27.4	31.2	155.0
+ Other Bank Balances	34.6	35.2	22.0	37.6	99.7
+ Short-term Loans	0.3	0.2	0.5	0.5	0.5
+ Other Current Financial Assets	5.5	14.4	11.3	16.0	13.4
Current Financial Assets	325.3	391.7	463.7	441.3	629.3
+ Other Current Assets	201.9	248.8	395.7	450.5	487.1
Total Current Assets	756.2	889.0	1,159.4	1,163.6	1,440.0
Total Assets	1,110.5	1,293.2	1,778.1	1,936.1	2,305.9
Equity
+ Equity Share Capital	102.2	102.2	109.6	109.6	109.6
+ Other Equity / Reserves	650.7	745.0	1,046.6	1,136.9	1,271.5
Equity — Owners of Parent	752.9	847.2	1,156.2	1,246.4	1,381.1
+ Minority Interest	-0.5	0.0	30.7	0.7	0.8
Total Equity	752.4	847.2	1,187.0	1,247.1	1,381.9
Liabilities
+ Borrowings — Non-current	0.9	3.4	25.8	133.6	121.2
+ Other Non-current Financial Liab	3.5	4.5	17.9	7.4	12.0
Non-current Financial Liabilities	4.5	7.9	43.7	141.0	133.2
+ Provisions — Non-current	29.7	33.8	39.8	41.2	41.5
+ Deferred Tax Liabilities	2.7	2.2	7.0	16.5	23.4
Non-current Liabilities	36.9	43.9	90.5	198.7	198.1
+ Borrowings — Current	24.2	25.6	53.6	61.1	183.8
+ Trade Payables	226.9	295.0	363.3	317.2	408.0
+ Other Current Financial Liab	50.1	50.5	42.5	44.2	73.9
Current Financial Liabilities	301.2	371.2	459.4	422.6	665.8
+ Provisions — Current	16.2	25.0	19.6	29.6	42.4
+ Other Current Liabilities	3.7	5.9	21.6	38.1	17.8
Current Liabilities	321.2	402.0	500.7	490.3	725.9
Total Liabilities	358.0	446.0	591.1	689.0	924.0
Total Equity & Liabilities	1,110.5	1,293.2	1,778.1	1,936.1	2,305.9
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	0.7	2.9	2.1
+ Dues to Other Creditors — Current	—	—	362.6	314.3	406.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.